알데이라 테라퓨틱스(Aldeyra Therapeutics)
US ˙ NasdaqCM ˙ US01438T1060

SecurityALDX / Aldeyra Therapeutics, Inc.
InstitutionPrivate Advisors, LLC
Latest Disclosed Ownership77,727 shares
Latest Disclosed Value $ 576,000
Private Advisors, LLC reports 25.92% decrease in ownership of ALDX / Aldeyra Therapeutics, Inc.

On November 13, 2020 - Private Advisors, LLC filed a 13F-HR form disclosing ownership of 77,727 shares of Aldeyra Therapeutics, Inc. (US:ALDX) valued at $575,957 USD as of September 30, 2020. The entity filed a previous 13F-HR on August 13, 2020 disclosing 104,926 shares of Aldeyra Therapeutics, Inc.. This represents a change in shares of -25.92% during the quarter. The current value of the position is $126,695 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-11-13 2020-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 77,727 -27,199 -25.92 576 31.51 0.4044
2020-08-13 2020-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 104,926 -32,304 -23.54 438 29.20 0.3170
2020-05-11 2020-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 137,230 48,916 55.39 339 -33.92 0.2998
2020-02-03 2019-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 88,314 39,812 82.08 513 100.39 0.4537
2019-11-08 2019-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 48,502 8,232 20.44 256 5.79 0.2521
2019-08-08 2019-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 40,270 7,211 21.81 242 -19.06 0.2202
2019-06-03 2019-03-31 13F/A-1 ALDEYRA THERAPEUTICS COM 01438T106 33,059 11,020 50.00 299 63.39 0.3140
2019-05-10 2019-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 33,151 11,112 299
2019-02-14 2018-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 22,039 22,039 183 0.1934
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.